DK283588A - Monoklonalt antistof mod ovariecancerceller - Google Patents

Monoklonalt antistof mod ovariecancerceller

Info

Publication number
DK283588A
DK283588A DK283588A DK283588A DK283588A DK 283588 A DK283588 A DK 283588A DK 283588 A DK283588 A DK 283588A DK 283588 A DK283588 A DK 283588A DK 283588 A DK283588 A DK 283588A
Authority
DK
Denmark
Prior art keywords
ovari
monoclonal antibody
cancer cells
antibody against
cancer
Prior art date
Application number
DK283588A
Other languages
English (en)
Other versions
DK283588D0 (da
Inventor
Ira Pastan
David J Fitzgerald
Mark Willingham
Original Assignee
Ira Pastan
David J Fitzgerald
Mark Willingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ira Pastan, David J Fitzgerald, Mark Willingham filed Critical Ira Pastan
Publication of DK283588A publication Critical patent/DK283588A/da
Publication of DK283588D0 publication Critical patent/DK283588D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A61K47/6855—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK283588A 1986-07-24 1988-05-24 Monoklonalt antistof mod ovariecancerceller DK283588D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/888,960 US4806494A (en) 1986-07-24 1986-07-24 Monoclonal antibody against ovarian cancer cells (OVB-3)
PCT/US1987/001667 WO1988000703A1 (en) 1986-07-24 1987-07-20 Monoclonal antibody against ovarian cancer cells (ovb-3)

Publications (2)

Publication Number Publication Date
DK283588A true DK283588A (da) 1988-05-24
DK283588D0 DK283588D0 (da) 1988-05-24

Family

ID=25394255

Family Applications (1)

Application Number Title Priority Date Filing Date
DK283588A DK283588D0 (da) 1986-07-24 1988-05-24 Monoklonalt antistof mod ovariecancerceller

Country Status (6)

Country Link
US (1) US4806494A (da)
EP (1) EP0277970A4 (da)
AU (1) AU7784187A (da)
DK (1) DK283588D0 (da)
IL (1) IL83291A0 (da)
WO (1) WO1988000703A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1289880C (en) * 1985-12-06 1991-10-01 Jeffrey L. Winkelhake Anti-human ovarian cancer immunotoxins and methods of use thereof
US4956453A (en) * 1985-12-06 1990-09-11 Cetus Corporation Anti-human ovarian cancer immunotoxins and methods of use thereof
US4962188A (en) * 1985-12-06 1990-10-09 Cetus Corporation Recombinant ricin toxin A chain conjugates
JPH02196799A (ja) * 1988-04-08 1990-08-03 Agency Of Ind Science & Technol 抗ヒト癌蛋白複合体
HU218603B (hu) * 1990-07-20 2000-10-28 Kabi Pharmacia Ab Célspecifikus antitest-szuperantigén konjugátumok és ezen készítmények előállítása
US5858363A (en) * 1990-07-20 1999-01-12 Pharmacia & Upjohn Ab Target specific antibody-superantigen conjugates and their preparation
ES2121792T3 (es) * 1990-10-12 1998-12-16 Us Health Anticuerpo monoclonal.
US5366866A (en) * 1991-07-25 1994-11-22 Duke University Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
US5484704A (en) * 1992-11-12 1996-01-16 Baylor College Of Medicine Monoclonal antibody for diagnostic use in ovarian cancer
US5690935A (en) * 1995-01-13 1997-11-25 Regents Of The University Of Minnesota Biotherapy of cancer by targeting TP-3/P80
US7192709B2 (en) * 2004-03-15 2007-03-20 Digigenomics Co., Ltd. Methods for identification, assessment, prevention, and therapy of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4664911A (en) * 1983-06-21 1987-05-12 Board Of Regents, University Of Texas System Immunotoxin conjugates employing toxin B chain moieties
US4666845A (en) * 1983-12-16 1987-05-19 Sloan-Kettering Institute Monoclonal antibodies to ovarian, cervical and uterine human cancers and method of diagnosis
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
US4678667A (en) * 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
DE3685485D1 (de) * 1985-12-06 1992-07-02 Cetus Corp Anti-immuntoxine gegen menschlichen eierstockkrebs und verfahren zu deren verwendung.

Also Published As

Publication number Publication date
EP0277970A1 (en) 1988-08-17
AU7784187A (en) 1988-02-10
IL83291A0 (en) 1987-12-31
US4806494A (en) 1989-02-21
DK283588D0 (da) 1988-05-24
EP0277970A4 (en) 1988-10-20
WO1988000703A1 (en) 1988-01-28

Similar Documents

Publication Publication Date Title
DK666389A (da) Monoklonalt antistof
DE3586188D1 (de) Antikoerper-metallionen-komplexe.
DE68914244D1 (de) Monoklonaler Antikörper.
DK398887D0 (da) Antistoffer
FI862761A (fi) Klonad antigen.
DE3885355D1 (de) Monoklonale Antikörper.
DK63187A (da) Krydsbeskyttende monoklonale antistofpraeparater
DK283588D0 (da) Monoklonalt antistof mod ovariecancerceller
DK188185A (da) Monoklonalt antistof
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DK717888A (da) Monoklonale antistoffer
DK37785D0 (da) Monoclonalt antistof
DK144485A (da) Monoklonale antistoffer
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
NO873488L (no) Monoklonale antistoffer.
DK474189A (da) Monoklonalt antistof
DK324287A (da) Antistof mod koensspecifikt antigen
NO890116L (no) Monoklonale antistoffer.
DK370089D0 (da) Anti-urokinase monoklonale antistoffer
DK413389D0 (da) Monoklonale antistoffer
DE3689183D1 (de) Monoklonaler Antiasialo-GM1-Antikörper.
DK554986D0 (da) Antistof
DK240286D0 (da) Monoklonale antistoffer
DK554886D0 (da) Antistoffer

Legal Events

Date Code Title Description
ATS Application withdrawn